Literature DB >> 23292496

A contemporary review of molecular candidates for the development and treatment of childhood medulloblastoma.

N Ceren Sümer-Turanlıgil1, Emel Öykü Cetin, Yiğit Uyanıkgil.   

Abstract

INTRODUCTION: Medulloblastoma is the most common pediatric central nervous system tumor; however, the causes are not well established. There has been some emphasis on mutations in developmental pathways and their impact on tumor pathology in hereditary diseases, but, in order to better understand the nature of diseases like medulloblastoma, other mechanisms also require attention.
PURPOSE: The purpose of this review is to provide an overview of the main genes involved in neurodevelopment, their downstream targets, and modulatory links by growth factors. Occurrence of pediatric brain tumors including medulloblastoma are mostly sporadic, but some hereditary diseases like Li-Fraumeni syndrome, Gorlin's syndrome, Turcot's syndrome, and Rubenstein-Tarbi syndrome are known to contribute their development as consequences of germline mutations at specific points: DNA-repairing gene Tp53 for Li-Fraumeni syndrome or Patch for Gorlin's, and apoptosis-related gene product adenomatous polyposis coli for Turcot's disease.
CONCLUSION: Intracellular relations at molecular level and future therapeutics that specifically target the corresponding pathways should be well understood in order to prevent and cure childhood medulloblastoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23292496     DOI: 10.1007/s00381-012-2014-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  63 in total

1.  Hedgehog controls neural stem cells through p53-independent regulation of Nanog.

Authors:  Agnese Po; Elisabetta Ferretti; Evelina Miele; Enrico De Smaele; Arianna Paganelli; Gianluca Canettieri; Sonia Coni; Lucia Di Marcotullio; Mauro Biffoni; Luca Massimi; Concezio Di Rocco; Isabella Screpanti; Alberto Gulino
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

2.  Medulloblastoma associated with novel PTCH mutation as primary manifestation of Gorlin syndrome.

Authors:  John R Crawford; Brian R Rood; Christopher T Rossi; Gilbert Vezina
Journal:  Neurology       Date:  2009-05-05       Impact factor: 9.910

Review 3.  Medulloblastoma: clinical and biologic aspects.

Authors:  R J Packer; P Cogen; G Vezina; L B Rorke
Journal:  Neuro Oncol       Date:  1999-07       Impact factor: 12.300

4.  Medulloblastoma: a disease with disorganized developmental signaling cascades.

Authors:  Ninib Baryawno; Baldur Sveinbjörnsson; Per Kogner; John Inge Johnsen
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

5.  Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.

Authors:  Silvia Buonamici; Juliet Williams; Michael Morrissey; Anlai Wang; Ribo Guo; Anthony Vattay; Kathy Hsiao; Jing Yuan; John Green; Beatriz Ospina; Qunyan Yu; Lance Ostrom; Paul Fordjour; Dustin L Anderson; John E Monahan; Joseph F Kelleher; Stefan Peukert; Shifeng Pan; Xu Wu; Sauveur-Michel Maira; Carlos García-Echeverría; Kimberly J Briggs; D Neil Watkins; Yung-mae Yao; Christoph Lengauer; Markus Warmuth; William R Sellers; Marion Dorsch
Journal:  Sci Transl Med       Date:  2010-09-29       Impact factor: 17.956

6.  Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.

Authors:  Karel Zitterbart; Hana Filkova; Lenka Tomasikova; Eva Necesalova; Iva Zambo; Dagmar Kantorova; Iva Slamova; Vladimira Vranova; Dita Zezulkova; Martina Pesakova; Zdenek Pavelka; Renata Veselska; Petr Kuglik; Jaroslav Sterba
Journal:  J Neurooncol       Date:  2010-07-08       Impact factor: 4.130

Review 7.  Hedgehog beyond medulloblastoma and basal cell carcinoma.

Authors:  Stephan Teglund; Rune Toftgård
Journal:  Biochim Biophys Acta       Date:  2010-01-18

Review 8.  The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors.

Authors:  Stephen D Skaper
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-02       Impact factor: 4.388

9.  Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion.

Authors:  Lowell Evan Michael; Bart A Westerman; Alexandre N Ermilov; Aiqin Wang; Jennifer Ferris; Jianhong Liu; Marleen Blom; David W Ellison; Maarten van Lohuizen; Andrzej A Dlugosz
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

Review 10.  Medulloblastoma.

Authors:  Girish Dhall
Journal:  J Child Neurol       Date:  2009-11       Impact factor: 1.987

View more
  4 in total

1.  Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.

Authors:  Mariane Jaeger; Carolina Nör; Caroline Brunetto de Farias; Ana Lucia Abujamra; Gilberto Schwartsmann; Algemir Lunardi Brunetto; Rafael Roesler
Journal:  Childs Nerv Syst       Date:  2013-10-03       Impact factor: 1.475

2.  EGF as a New Therapeutic Target for Medulloblastoma Metastasis.

Authors:  Jennifer Rico-Varela; Tanya Singh; Sean McCutcheon; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2015-06-04       Impact factor: 2.321

3.  Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cells.

Authors:  Raquel Ordóñez; Gabriel Gallo-Oller; Soledad Martínez-Soto; Sheila Legarra; Noémie Pata-Merci; Justine Guegan; Giselle Danglot; Alain Bernheim; Bárbara Meléndez; Juan A Rey; Javier S Castresana
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

4.  Magnetic Resonance Imaging Features of Common Posterior Fossa Brain Tumors in Children: A Preliminary Vietnamese Study.

Authors:  Nguyen Minh Duc; Huynh Quang Huy
Journal:  Open Access Maced J Med Sci       Date:  2019-08-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.